...
首页> 外文期刊>Journal of Medicinal Chemistry >Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials
【24h】

Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials

机译:第二代基于四氢喹啉的蛋白质法呢基转移酶抑制剂作为抗疟药

获取原文
获取原文并翻译 | 示例

摘要

Substituted tetrahydroquinolines (THQs) have been previously identified as inhibitors of mammalian protein farnesyltransferase (PFT). Previously we showed that blocking PFT in the malaria parasite led to cell death and that THQ-based inhibitors are the most potent among several structural classes of PFT inhibitors (PFTIs). We have prepared 266 THQ-based PFTIs and discovered several compounds that inhibit the malarial enzyme in the sub- to low-nanomolar range and that block the growth of the parasite (P. falciparum) in the lownanomolar ran-e. This body of structure- activity data can be rationalized in most cases by consideration of the X-ray structure of one of the THQs bound to mammalian PFT together with a homology structural model of the malarial enzyme. The results of this study provide the basis for selection of antimalarial PFTIs for further evaluation in preclinical drug discovery assays.
机译:取代四氢喹啉(THQs)先前已被确定为哺乳动物蛋白法呢基转移酶(PFT)的抑制剂。以前,我们表明在疟疾寄生虫中阻断PFT会导致细胞死亡,而基于THQ的抑制剂是PFT抑制剂(PFTI)的几种结构类别中最有效的。我们已经制备了266种基于THQ的PFTI,并发现了几种化合物,它们在亚纳摩尔到低纳摩尔范围内抑制疟疾酶,并在低纳摩尔范围内阻止寄生虫(恶性疟原虫)的生长。在大多数情况下,可以通过考虑与哺乳动物PFT结合的THQ之一的X射线结构以及疟疾酶的同源性结构模型来使这种结构活性数据合理化。这项研究的结果为选择抗疟药PFTIs进行临床前药物发现试验的进一步评估提供了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号